Ondansetron HCL 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FN1H1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,567
Award facts
- Contract value 100% obligated
- $24,567.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,567.41 to Amerisourcebergen Drug Corp for the supply of Ondansetron HCl 4 mg tablets (30-count) on January 29, 2026, with completion expected by January 30, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. The award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Ondansetron is a commonly prescribed antiemetic medication used to prevent nausea and vomiting, particularly in military and veteran healthcare settings. This delivery order exemplifies the routine pharmaceutical procurement conducted through DLA's prime vendor contracts, which enable efficient supply of essential medications across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Amerisourcebergen Drug Corp maintains a significant portfolio of federal contract awards demonstrating its capability to fulfill open competition requirements across a diverse range of pharmaceutical products and therapeutic domains, positioning it as a critical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FN1H1?
SPE2DR26FN1H1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FN1H1 worth?
The government has obligated $24,567 on SPE2DR26FN1H1.
Is contract SPE2DR26FN1H1 an order under another contract?
Yes. SPE2DR26FN1H1 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN1H1 competed?
The extent of competition for SPE2DR26FN1H1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award